These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. What they say about nucleotide drugs. Posit Aware; 1999; 10(1):44. PubMed ID: 11366523 [TBL] [Abstract][Full Text] [Related]
3. FDA panel fails to recommend adefovir approval. Food and Drug Administration. Highleyman L BETA; 1999; 12(4):4. PubMed ID: 11367249 [TBL] [Abstract][Full Text] [Related]
6. NDA submitted for adefovir. AIDS Patient Care STDS; 1999 Sep; 13(9):567. PubMed ID: 10813037 [No Abstract] [Full Text] [Related]
7. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated. Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro. Miller MD; Anton KE; Mulato AS; Lamy PD; Cherrington JM J Infect Dis; 1999 Jan; 179(1):92-100. PubMed ID: 9841827 [TBL] [Abstract][Full Text] [Related]
12. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too]. MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303 [No Abstract] [Full Text] [Related]
14. Tenofovir: FDA hearing on important new antiretroviral. James JS AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411 [No Abstract] [Full Text] [Related]
15. FDA notifications. Two tenofovir containing products are approved. AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795142 [No Abstract] [Full Text] [Related]
16. New uses for tenofovir: more questions about d4T. Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676 [TBL] [Abstract][Full Text] [Related]
17. Advances in therapy for chronic hepatitis B. Marcellin P Semin Liver Dis; 2002; 22 Suppl 1():33-6. PubMed ID: 12447727 [TBL] [Abstract][Full Text] [Related]
18. FDA notifications. Complera approved. AIDS Alert; 2011 Nov; 26(11):130-1. PubMed ID: 22164521 [No Abstract] [Full Text] [Related]